CVRx to Report Second Quarter 2022 Financial and Operating Results and Host Conference CallGlobeNewsWire • 07/14/22
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure SystemGlobeNewsWire • 05/09/22
CVRx, Inc.'s (CVRX) CEO Nadim Yared on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/25/22
CVRx to Report First Quarter 2022 Financial and Operating Results and Host Conference CallGlobeNewsWire • 04/12/22
CVRx, Inc. (CVRX) CEO Nadim Yared on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/16/22
CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating ResultsGlobeNewsWire • 02/15/22
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial ResultsGlobeNewsWire • 01/10/22
CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/16/21
CVRx, Inc. (CVRX) CEO Nadim Yared on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/07/21
CVRx, Inc. (CVRX) CEO Nadim Yared on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
CVRx to Report Second Quarter 2021 Financial and Operating Results and Host Conference CallGlobeNewsWire • 07/21/21
CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of DirectorsGlobeNewsWire • 07/12/21
Treo Ventures Announces the Successful IPO of its Portfolio Company CVRx® (NSDQ: CVRX)PRNewsWire • 07/06/21
CVRx, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 07/02/21